Presentation JIM 2019 GP IIb/IIIa inhibitors are still the best option Presenter: Alberto Menozzi February 15, 2019
Presentation TCT 2014 Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in Those Undergoing PCI Presenter: Frederick Feit, Sripal Bangalore September 13, 2014
Presentation TCT 2014 Are GP IIb/IIIa Inhibitors Still Useful? Presenter: Marco Valgimigli September 13, 2014
Presentation EuroPCR 2014 Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial Presenter: Uwe Zeymer May 21, 2014
Presentation TCT 2013 Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI Presenter: Sripal Bangalore October 27, 2013
Presentation Fellows 2012 Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors Presenter: George Dangas April 22, 2012